Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma.

Castro M, Rabe KF, Corren J, Pavord ID, Katelaris CH, Tohda Y, Zhang B, Rice MS, Maroni J, Rowe P, Pirozzi G, Amin N, Ruddy M, Akinlade B, Graham NMH, Teper A.

ERJ Open Res. 2020 Jan 27;6(1). pii: 00204-2019. doi: 10.1183/23120541.00204-2019. eCollection 2020 Jan.

2.

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.

Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A.

J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526. doi: 10.1016/j.jaip.2019.08.050. Epub 2019 Sep 12.

3.

Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history.

Corren J, Castro M, Ford LB, Bernstein JA, Jayawardena S, Maroni J, Rowe P, Amin N, Pirozzi G, Graham NMH, Khan A, Eckert L, Teper A.

Ann Allergy Asthma Immunol. 2019 Aug;123(2):222-224.e1. doi: 10.1016/j.anai.2019.04.028. Epub 2019 May 8. No abstract available.

4.

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps.

Bhattacharyya N, Villeneuve S, Joish VN, Amand C, Mannent L, Amin N, Rowe P, Maroni J, Eckert L, Yang T, Khan A.

Laryngoscope. 2019 Sep;129(9):1969-1975. doi: 10.1002/lary.27852. Epub 2019 Feb 5.

5.

Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma.

Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, Graham NMH, Teper A.

J Allergy Clin Immunol. 2018 Jul;142(1):171-177.e1. doi: 10.1016/j.jaci.2017.11.051. Epub 2018 Jan 31.

6.

Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.

Müller-Wieland D, Leiter LA, Cariou B, Letierce A, Colhoun HM, Del Prato S, Henry RR, Tinahones FJ, Aurand L, Maroni J, Ray KK, Bujas-Bobanovic M.

Cardiovasc Diabetol. 2017 May 25;16(1):70. doi: 10.1186/s12933-017-0552-4.

7.

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial.

Cariou B, Leiter LA, Müller-Wieland D, Bigot G, Colhoun HM, Del Prato S, Henry RR, Tinahones FJ, Letierce A, Aurand L, Maroni J, Ray KK, Bujas-Bobanovic M.

Diabetes Metab. 2017 Oct;43(5):453-459. doi: 10.1016/j.diabet.2017.01.004. Epub 2017 Mar 24.

8.

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia.

Kastelein JJ, Kereiakes DJ, Cannon CP, Bays HE, Minini P, Lee LV, Maroni J, Farnier M.

Coron Artery Dis. 2017 May;28(3):190-197. doi: 10.1097/MCA.0000000000000438.

9.

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC; Treating to New Targets Investigators.

N Engl J Med. 2007 Sep 27;357(13):1301-10.

10.

[Operative risk of heart valve surgery after 80 years].

Hanania G, Maroni JP.

Ann Cardiol Angeiol (Paris). 2005 Nov;54(6):339-43. Review. French.

PMID:
17183830
11.

Questions for COPD diagnostic screening in a primary care setting.

Freeman D, Nordyke RJ, Isonaka S, Nonikov DV, Maroni JM, Price D, Halbert RJ.

Respir Med. 2005 Oct;99(10):1311-8. Epub 2005 Apr 18.

12.

Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting.

van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D.

Respirology. 2005 Jun;10(3):323-33.

PMID:
15955145
13.

Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study).

Blank R, LaSalle J, Reeves R, Maroni J, Tarasenko L, Sun F.

J Clin Hypertens (Greenwich). 2005 May;7(5):264-73.

14.

[Can bioprostheses be implanted at younger ages?].

Maroni JP, Montely JM, Terdjman M, Hanania G.

Ann Cardiol Angeiol (Paris). 2004 Nov;53(6):294-7. Review. French.

PMID:
15603170
15.

[Anticoagulation of valvular prostheses].

Hanania G, Maroni JP, el Hajj Y.

Ann Cardiol Angeiol (Paris). 2003 Nov;52(5):290-6. Review. French.

PMID:
14714342
16.

[The best of valvular heart disease in 2002].

Hanania G, Acar C, Michel PL, Maroni JP; Groupe de travail sur les valvulopathies de la Société européenne de cardiologie.

Arch Mal Coeur Vaiss. 2003 Jan;96 Spec No 1:87-94. Review. French.

PMID:
12613368
17.

[Aortic stenosis with left ventricular dysfunction: evaluation and management].

Hanania G, Terdjman M, Montely JM, Maroni JP.

Ann Cardiol Angeiol (Paris). 2002 Nov;51(5):275-81. Review. French.

PMID:
12515104
18.

[The best of 2001. Valve diseases].

Hanania G, Maroni JP, Michel PL.

Arch Mal Coeur Vaiss. 2002 Jan;95 Spec No 1(5 Spec 1):67-73. Review. French.

PMID:
11901903
19.

Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.

Crystal RG, Harvey BG, Wisnivesky JP, O'Donoghue KA, Chu KW, Maroni J, Muscat JC, Pippo AL, Wright CE, Kaner RJ, Leopold PL, Kessler PD, Rasmussen HS, Rosengart TK, Hollmann C.

Hum Gene Ther. 2002 Jan 1;13(1):65-100.

PMID:
11779413
20.

Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions.

Harvey BG, Maroni J, O'Donoghue KA, Chu KW, Muscat JC, Pippo AL, Wright CE, Hollmann C, Wisnivesky JP, Kessler PD, Rasmussen HS, Rosengart TK, Crystal RG.

Hum Gene Ther. 2002 Jan 1;13(1):15-63.

PMID:
11779412
21.

[The best in 2000 on valve diseases].

Hanania G, Maroni JP.

Arch Mal Coeur Vaiss. 2001 Jan;94 Spec No 1:91-8. Review. French.

PMID:
11260845
22.

Maximum cardiac output during incremental exercise by first-pass radionuclide ventriculography.

Maroni JM, Oelberg DA, Pappagianopoulos P, Boucher CA, Systrom DM.

Chest. 1998 Aug;114(2):457-61.

PMID:
9726730
23.

[Indications of coronary angioplasty after thrombolysis].

Vahanian A, Garbarz E, Nallet O, Porte JM, Michel PL, Maroni JP, Louvard Y, Jais JM.

Arch Mal Coeur Vaiss. 1995 Aug;88 Spec No 3:19-24. Review. French.

PMID:
7503613
24.

[Complex cardiac lesion diagnosed more than 20 years after the causal injury].

Maroni JP, Terdjman M, Montély JM, Ghannem M, Mesnildrey P, Hanania G.

Arch Mal Coeur Vaiss. 1994 Jul;87(7):949-52. French.

PMID:
7702442
25.

[Prosthetic valve endocarditis: current problems].

Maroni JP, Terdjman M, Montély JM, Hanania G.

Arch Mal Coeur Vaiss. 1993 Dec;86(12 Suppl):1837-43. Review. French.

PMID:
8024389
26.

[Contribution of antimyosin antibody myocardial scintigraphy in the diagnosis of acute myocarditis].

Weinmann P, Le Guludec D, Kebbou M, Bouton S, Maroni JP, Namade M, Faraggi M, Moretti JL.

Arch Mal Coeur Vaiss. 1993 Mar;86(3):297-305. French.

PMID:
8215764
27.

[Other indications of thrombolysis: thrombolysis in the elderly, late thrombolysis].

Vahanian A, Nallet O, Maroni JP, Acar J.

Arch Mal Coeur Vaiss. 1992 May;85(5 Suppl):713-9. Review. French.

PMID:
1530413
28.

Immediate and mid-term results of percutaneous mitral commissurotomy.

Vahanian A, Michel PL, Cormier B, Ghanem G, Vitoux B, Maroni JP, Cazaux P, Acar J.

Eur Heart J. 1991 Jul;12 Suppl B:84-9.

PMID:
1936033
29.

Cerebral blood flow in the anaesthetized immature sheep fetus and the response to hypercapnia.

Habgood MD, Jones SE, Maroni JM, Pickard JD, Richards HK, Saunders NR.

Exp Physiol. 1991 Jul;76(4):495-505.

30.

[Delays in hospital admissions of myocardial infarction].

Maroni JP, Montély JM, Poulain JM, Terdjman M, Champeau B, Hanania G.

Arch Mal Coeur Vaiss. 1990 Nov;83(12):1823-9. Review. French.

PMID:
2125193
31.

Effects of pre and postweaning footshock on the later competitive behavior of rats in a straight runway.

Maroni JB, Masur J.

Behav Biol. 1975 Jun;14(2):209-20. No abstract available.

PMID:
1137543
32.

Genetically selected winner and loser rats in the tunnel competition: influence of apomorphine and dopa.

Masur J, Maroni JB, Benedito MA.

Behav Biol. 1975 May;14(01):21-30. No abstract available.

PMID:
1137532
33.

Pubertad precoz por tumor de células de la granulosa.

TACHELLA COSTA A, BRACHETTO-BRIAN D, MARONI JJ.

Rev Asoc Med Argent. 1948 Aug 15-30;62(635-636):401-4. Undetermined Language. No abstract available.

PMID:
18887110
34.

Hernia de Littré.

SCHENA AT, MARONI JJ, SCOPINARO DI.

Prensa Med Argent. 1947 Jun 13;34(24):1096. Undetermined Language. No abstract available.

PMID:
20254226

Supplemental Content

Loading ...
Support Center